All posts by: Michael Zand

About Michael Zand

Stem Cells Guided by Electric Fields May Offer New Therapies for Brain Diseases – Genetic Engineering & Biotechnology News (press release)

Continue reading

2017-07-12 NEWS

Stem Cells Guided by Electric Fields May Offer New Therapies for Brain Diseases
Genetic Engineering & Biotechnology News (press release)
Scientists at the University of California, Davis School of Medicine’s Institute for Regenerative Cures report that electric fields can be used to guide neural stem cells transplanted into the brain towards a specific location. Their study (“Electrical

Continue reading

2017-07-12 NEWS

Technology Networks

Benefits of Droplet Digital PCR to Measure Immunotherapy Response Highlighted at ASCO Annual Meeting
Technology Networks
In one ASCO study, physicians used ddPCR technology to distinguish between tumor growth and pseudoprogression — a common conundrum in cancer immunotherapy. Tumors can appear to grow before they begin to shrink as a result of treatment, …

Continue reading

2017-07-12 NEWS

Technology Networks

ASCO Annual Meeting Highlights Benefits of Droplet Digital PCR to Measure Immunotherapy
Technology Networks
In one ASCO study, physicians used ddPCR technology to distinguish between tumor growth and pseudoprogression — a common conundrum in cancer immunotherapy. Tumors can appear to grow before they begin to shrink as a result of treatment, …

Continue reading

2017-07-12 NEWS

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives.
UroToday
The responsiveness of bladder cancer to immunotherapy was first established in nonmuscle invasive disease in 1976 with intravesical instillations of bacillus Calmette-Guérin (BCG). Very recently immune checkpoint inhibitors demonstrated good activity

Continue reading

2017-07-12 NEWS

pulse

Korea’s first gene therapy Invossa cleared to be sold in Korea …
pulse
South Korea’s Kolon Life Science said on Wednesday the Ministry of Food and Drug Safety has granted marketing approval to its new gene therapy to treat …
Korea OKs first cell gene therapy ‘Invossa’The Korea Herald
Ministry approves 1st domestic gene therapy product – Korea …Korea Biomedical Review
S. Korea approves 1st gene therapy drug – Yonhap News AgencyYonhap News

all 4 news articles »

Continue reading

2017-07-12 NEWS

The Korea Herald

Korea OKs first cell gene therapy ‘Invossa’
The Korea Herald
Korea’s Ministry of Food and Drug Safety has granted approval to Invossa-K Inj., an injectable cell gene therapy for osteoarthritis, a joint disease common among the elderly in which the cartilage that cushions the ends of bones between joints breaks down.